.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Federal Trade Commission
QuintilesIMS
Cerilliant
Teva
Fish and Richardson
Daiichi Sankyo
McKesson
Chubb
Farmers Insurance

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088004

« Back to Dashboard

NDA 088004 describes THIORIDAZINE HYDROCHLORIDE, which is a drug marketed by Actavis Mid Atlantic, Alpharma Us Pharms, Ani Pharms Inc, Hi Tech Pharma, Pharm Assoc, Sandoz, Wockhardt, Mutual Pharm, Mylan, Par Pharm, Roxane, Sun Pharm Industries, Superpharm, Watson Labs, Watson Labs Teva, and West Ward, and is included in seventy-nine NDAs. It is available from four suppliers. Additional details are available on the THIORIDAZINE HYDROCHLORIDE profile page.

The generic ingredient in THIORIDAZINE HYDROCHLORIDE is thioridazine hydrochloride. There are eighteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the thioridazine hydrochloride profile page.

Summary for 088004

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details

Pharmacology for NDA: 088004

Ingredient-typePhenothiazines

Suppliers and Packaging for NDA: 088004

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 088004 ANDA Mylan Pharmaceuticals Inc. 0378-0612 0378-0612-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0612-01)
THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 088004 ANDA Mylan Pharmaceuticals Inc. 0378-0614 0378-0614-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0614-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Nov 18, 1983TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Mar 15, 1983TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Mar 15, 1983TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
UBS
US Department of Justice
Cantor Fitzgerald
Fish and Richardson
Daiichi Sankyo
McKesson
Johnson and Johnson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot